SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy Enterprises is seeing significant investor attention driven by a combination of strong preliminary Q1 results and a strategic joint venture with Cerberus aimed at scaling American-made energy storage for AI data centers. While the community is actively debating the stock's massive short interest and potential for a squeeze, many are focused on the company's ability to maintain production momentum and successfully navigate its infrastructure build-out.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is experiencing high volatility as investors weigh the stock's role in the AI landscape against ongoing geopolitical concerns ahead of a high-stakes trade summit. The community remains deeply divided, with some traders actively accumulating shares in anticipation of a potential breakout, while others emphasize the stock's history as a value trap prone to sharp price swings.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending after confirming that the REGAL clinical trial has reached 78 of 80 events, signaling that final topline results and unblinding are imminent. Investors are actively discussing the potential for a significant short squeeze due to high short interest, while long-term supporters remain focused on the potential of the GPS treatment to transform AML care.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is facing intense bearish pressure and volatility, leaving retail investors divided between those buying the dip for its long-term AI potential and others frustrated by stagnant price action following recent earnings. Market participants are actively debating whether the stock is being suppressed by institutional manipulation and short-selling campaigns or if it is simply undergoing a necessary correction after being priced for perfection.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate whether current price levels represent a deep-value opportunity or a value trap, with the community closely tracking the firm's pivot toward agentic AI orchestration and enterprise integration partnerships. While many participants express frustration over persistent share price weakness and perceived manipulation, others are aggressively accumulating shares, citing a strong cash position, absence of debt, and long-term growth potential as the market potentially rotates toward quality AI software.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is surging as investors pile into the space sector ahead of an upcoming earnings report and anticipated major contract awards. The community is buzzing with high conviction in the companys long-term infrastructure narrative, often comparing it to a high-growth play and debating its potential to reach triple-digit valuations.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is trending as the community debates a potential bullish breakout from a cup-and-handle pattern ahead of upcoming quarterly earnings, while speculators closely monitor high-stakes trade discussions between US and Chinese leadership. Investors remain divided, with long-term supporters highlighting the expansion of battery-swap infrastructure and new model launches, while bears continue to focus on dilution concerns and significant technical resistance.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is generating significant market interest as it transitions into a dual-focus strategy, balancing its established truck and commercial businesses with a new 'Ford Energy' subsidiary dedicated to battery storage for data centers and industrial clients. Investors are closely tracking these infrastructure moves alongside the upcoming reveal of its affordable EV pickup, while the community remains divided between concerns over ongoing automotive recalls and optimism regarding the potential for institutional growth in the shifting energy economy.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is driving intense market engagement as investors track its aggressive multi-billion dollar capital expenditure plans and massive revenue growth, which have sparked a debate between those betting on long-term infrastructure dominance and those concerned about potential financing risks. Community discussions are centered on the company's ambitious power capacity buildout and its ability to scale as a pure-play AI hyperscaler, making it a focal point for traders anticipating volatility around earnings.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is experiencing intense volatility driven by high-conviction retail interest in its role as a specialized memory player for edge AI, defense, and space-based infrastructure. Community sentiment is deeply divided between long-term investors tracking institutional moves and potential supply-chain tailwinds, and skeptics who caution that the rapid price surge and low-float dynamics resemble a speculative squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$VKTX 

Let’s set this straight, you shouldn’t be giving medical advice and posts on social media do not constitute facts. Theoretically, glucagon spares muscle but there’s not a ton of clinical evidence that bears that out. Glucagon does however worsen nausea/vomiting, add palpitations/dysesthsias and worsen A1C control versus Tirzepatide.

FYI, Retatrutide isn’t FDA approved yet so those using it are technically buying from a black/grey market. Also, many of the community doing Reta are also on Testosterone or SARMs. The fitness industry is full of a lot of people who are doping if you weren’t aware. There is nothing to date to suggest that Retatrutide spares significant lean mass (ie skeletal muscle) vs other GLPs.

Here’s some actual facts from Lancet…

hornetsnest23

GTL91

KnysnaNow

Victor Jade

Ave Belder

Sanders Cupac

Pigeon

Will C.

Wendi

Timtimtim8484

robert

@SBL71 fair point but all roads are pointing towards monster at this point. If people don’t understand the glucagon binding aspect and fat loss versus muscle loss, they shouldn’t be investing in the space. Absolute potential monster they have on their hands. ￼

StockTwits for iOS

Family Office

Viking Therapeutics Inc

 

Let’s set this straight, you shouldn’t be giving medical advice and posts on social media do not constitute facts. Theoretically, glucagon spares muscle but there’s not a ton of clinical evidence that bears that out. Glucagon does however worsen nausea/vomiting, add palpitations/dysesthsias and worsen A1C control versus Tirzepatide.

FYI, Retatrutide isn’t FDA approved yet so those using it are technically buying from a black/grey market. Also, many of the community doing Reta are also on Testosterone or SARMs. The fitness industry is full of a lot of people who are doping if you weren’t aware. There is nothing to date to suggest that Retatrutide spares significant lean mass (ie skeletal muscle) vs other GLPs.

Here’s some actual facts from Lancet…

D.G.

@DG20 I wish all to make money in their investments! Not necessarily bearish on vktx and really respect semodough on X who is a big supporter, BUT I wouldnt be so quick to write off the overhang on both the market and the acquisition market with the potential impact of R hanging out in space. You seem like an informed researcher which puts you head and shoulders above most on ST but all investors need to guard against our own bias. Good luck! Truly mean it!

 I wish all to make money in their investments! Not necessarily bearish on vktx and really respect semodough on X who is a big supporter, BUT I wouldnt be so quick to write off the overhang on both the market and the acquisition market with the potential impact of R hanging out in space. You seem like an informed researcher which puts you head and shoulders above most on ST but all investors need to guard against our own bias. Good luck! Truly mean it!

@RandandKaren 

LLY is the largest pharmaceutical company in the world by a mile. Everything they’ve done in the last 5 years has been BIC and Reta has enormous potential due to massive WL. That said, the glucagon argument  of muscle sparing is simply not true with data available to date.

 

LLY is the largest pharmaceutical company in the world by a mile. Everything they’ve done in the last 5 years has been BIC and Reta has enormous potential due to massive WL. That said, the glucagon argument  of muscle sparing is simply not true with data available to date.

@DG20 point taken and you are correct. Seems my statement was more anecdotal than data driven. But if P3 shows the same robust cholesterol, ldl C, and triglyceride improvements….good night….

 point taken and you are correct. Seems my statement was more anecdotal than data driven. But if P3 shows the same robust cholesterol, ldl C, and triglyceride improvements….good night….

@RandandKaren 

Lipids is a very different argument. It’s effective there but think about the population who’d benefit the most, the population most likely to have side effects. Older persons with comorbidies, just saying…

 

Lipids is a very different argument. It’s effective there but think about the population who’d benefit the most, the population most likely to have side effects. Older persons with comorbidies, just saying…